Hetquenil 400 Tablet is being evaluated in several clinical trials for its potential use in preventing COVID-19 and treating individuals infected with the novel coronavirus. While early laboratory studies (in vitro) have shown that the medication may have some antiviral activity, current evidence is not sufficient to confirm its effectiveness in clinical settings. More research is needed to establish its safety and efficacy for this specific use.

The ICMR-appointed national task force for COVID-19 has advised that Hetquenil 400 Tablet may be considered for preventive use only in specific high-risk groups. This includes asymptomatic healthcare professionals who are directly caring for suspected or confirmed COVID-19 patients, as well as asymptomatic individuals who are household contacts of confirmed cases. Its use is limited to such emergency scenarios and should be strictly under medical supervision.

There is no need to stockpile Hetquenil 400 Tablet. If you believe you may have contracted COVID-19, seek medical attention promptly and follow your doctor’s guidance. Do not take Hetquenil 400 Tablet without a proper prescription, as it should only be used under the supervision of a qualified healthcare provider.

Hetquenil 400 Tablet is advised for coronavirus prevention only in specific high-risk individuals or during medical emergencies. It must be used exactly as directed by your doctor, including the prescribed dose, timing, and duration.